Compound Detail
CHEMBL3633071
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CCCCCCCCCCCCCCNC(=O)C[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3
Basic Information
| ChEMBL ID | CHEMBL3633071 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | NAPCDHJLYZGYOO-DFEJUYRRSA-N |
2
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
521.8
MW (Da)
7.44
ALogP
5
HBA
1
HBD
66.0
PSA (Ų)
0.18
QED
2
Ro5 Violations
15
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 6.34
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | IC50 | = | 460.0 | nM | 6.34 | Cytotoxicity against human HepG2 cells by MTT assay | 26318055 |
| HepG2 | IC50 | = | 460.0 | nM | 6.34 | Antiproliferative activity against human HepG2 cells assessed as inhibition of c... | 36538859 |
| CCD 19Lu | IC50 | = | 460.0 | nM | 6.34 | Cytotoxicity against human CCD 19Lu cells assessed as inhibition of cell growth | 36538859 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 26318055 | 10.1016/j.ejmech.2015.08.035 | HepG2 | 1 |
| 36538859 | 10.1016/j.ejmech.2022.115000 | HepG2 | 1 |
| 36538859 | 10.1016/j.ejmech.2022.115000 | CCD 19Lu | 1 |
Data from ChEMBL 36 via Core Engine